Douglas Wallis

Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada.

Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada.

Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada.

Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada.